INSRR: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 32: Line 32:
[[Category:Immune system]]
[[Category:Immune system]]
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 14:26, 17 March 2025

IL1RN

The IL1RN gene encodes the interleukin 1 receptor antagonist (IL-1Ra), a critical component of the immune system that modulates the activity of interleukin 1 (IL-1). IL-1 is a cytokine that plays a key role in the inflammatory response, and IL-1Ra serves as a natural inhibitor of this cytokine, preventing excessive inflammation and tissue damage.

Structure[edit]

The IL1RN gene is located on chromosome 2q14.2 and consists of four exons. The protein product, IL-1Ra, is a member of the interleukin 1 cytokine family and is structurally similar to IL-1α and IL-1β, but it lacks the ability to bind to the IL-1 receptor and initiate signal transduction. Instead, IL-1Ra competes with IL-1α and IL-1β for binding to the IL-1 receptor, thereby blocking their pro-inflammatory effects.

Function[edit]

IL-1Ra is primarily produced by monocytes, macrophages, and other cells in response to inflammatory stimuli. It acts as a competitive inhibitor of IL-1 by binding to the IL-1 receptor without activating it, thus preventing IL-1 from exerting its effects. This regulation is crucial for maintaining the balance of the immune response and preventing chronic inflammation.

Clinical Significance[edit]

Mutations or polymorphisms in the IL1RN gene have been associated with various inflammatory and autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease. Additionally, recombinant IL-1Ra (anakinra) is used therapeutically to treat conditions like rheumatoid arthritis and other inflammatory disorders by mimicking the natural inhibitory effects of IL-1Ra.

Research and Therapeutic Use[edit]

Research into IL1RN and its protein product has led to the development of targeted therapies aimed at modulating the IL-1 pathway. Anakinra, a recombinant form of IL-1Ra, is used to treat rheumatoid arthritis and other inflammatory conditions by reducing inflammation and slowing disease progression.

Genetic Variants[edit]

Several polymorphisms in the IL1RN gene have been identified, some of which are associated with altered levels of IL-1Ra production and susceptibility to inflammatory diseases. The most studied polymorphism is a variable number tandem repeat (VNTR) in intron 2, which has been linked to various inflammatory conditions.

Also see[edit]